Oct 19, 2023 by James Halley3 Things About Bristol Myers Squibb That Smart Investors KnowThe stock is down this year, but will its struggles fade into the rearview mirror?
Oct 19, 2023 by James Halley4 Ways to Grow $100,000 Into $1 Million for RetirementInvesting for big-time growth doesn't have to be risky.
Oct 19, 2023 by James Halley3 Under-the-Radar Biotech Stocks to Buy in 2023These three lesser-known biotech companies are profitable and growing revenue.
Oct 19, 2023 by James HalleyWhich Is the Better Cannabis Growth Stock for You: Cresco Labs or TerrAscend?Cannabis stocks are back in style, but is either one of these multi-state operators a long-term buy?
Oct 14, 2023 by James Halley2 Robinhood Stocks With Market-Beating PotentialThese diamonds in the rough won't stay down.
Oct 13, 2023 by James HalleyWhy Shares of Revolution Medicines Were Popping on FridayThe company released positive phase 1/1b trial data on two cancer therapies.
Oct 13, 2023 by James HalleyWhy Shares of Harmony Bioscience Are Falling on FridayThe company reported underwhelming phase 3 trial results for Pitolisant to treat idiopathic hypersomnia.
Oct 13, 2023 by James HalleyWhy Shares of T2 Biosystems Are Falling FridayA revenue drop and a reverse stock split worried investors.
Oct 12, 2023 by James HalleyWhy Shares of Insulet Dropped This WeekPositive news regarding diabetes therapy Ozempic worried investors.
Oct 12, 2023 by James HalleyWhy Akero Therapeutics Shares Are Slumping This WeekAkero's lead therapy fell short of its goals in a phase 2b trial to treat NASH.
Oct 12, 2023 by James HalleyWhy Shares of ProKidney Were Dropping ThursdayTwo factors led to the stock's slide on Thursday.
Oct 11, 2023 by James HalleyWhy Shares of Ardelyx Were Down WednesdayThe company's hopes for approval of a drug to treat chronic kidney disease took a hit.
Oct 11, 2023 by James HalleyWhy Shares of Sharecare Are Soaring on WednesdayThe company's stock climbed after a proposal by a private equity firm to buy up available stock.
Oct 11, 2023 by James HalleyWhy Shares of Fresenius Medical Care Were Dropping on WednesdayPositive trial news for a kidney failure drug could cut into business for dialysis therapies companies such as Fresenius.
Oct 11, 2023 by James HalleyWhy Shares of Silk Road Medical Are Dropping WednesdayThe company's CEO stepped down and the company reduced top-line yearly guidance.
Oct 10, 2023 by James HalleyWhy Shares of 89bio Plummeted on TuesdaySo-so trial data for a competitor's NASH therapy candidate that is similar to 89bio's candidate spooked investors.
Oct 10, 2023 by James HalleyWhy Shares of Erasca Are Jumping TuesdayThe company's chairman and CEO bought more than $2.025 million worth of company stock.
Oct 10, 2023 by James HalleyWhy Shares of Ventyx Biosciences Are Dropping TuesdayInvestors were unimpressed by the company's trial results for an ulcerative colitis therapy.
Oct 10, 2023 by James HalleyWhy Shares of Lexicon Pharmaceuticals Are Up TuesdayExpress Scripts will give its clients access to Lexicon's first approved therapy.
Oct 9, 2023 by James HalleyWhy Shares of Scilex Are Up MondayAn analyst at H.C. Wainwright initiated coverage on the stock.
